Compound useful for the treatment of degenerative and inflammatory diseases

A novel compound able to inhibit JAK is disclosed, that comprises a compound of Formula I:The compound may be prepared as a pharmaceutical composition, and may be used for the treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory con...

Full description

Saved in:
Bibliographic Details
Main Authors Menet, Christel Jeanne Marie, Smits, Koen Kurt
Format Patent
LanguageEnglish
Published 23.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel compound able to inhibit JAK is disclosed, that comprises a compound of Formula I:The compound may be prepared as a pharmaceutical composition, and may be used for the treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6.
Bibliography:Application Number: US202117230483